Industry Events
EnglishFrançaisEspañol中文العربية
EventsNewsInsightsOrganisers
Services
  • Event MarketingList, promote and grow your events to a global B2B audience.
  • Press ReleaseDistribute official announcements to industry professionals worldwide.
  • Speaker & SME PromotionShowcase expertise, get booked for keynotes, panels and masterclasses.
Subscribe
Speaker Sign InList Your Free Event
Industry Events

The world's most trusted B2B event discovery platform. Connecting industry professionals with the conferences, expos and summits that matter.

  • Industry Events
  • News
  • Event Organisers
  • About Us
  • Our Services
  • Premium Organiser
  • Event Pro
  • Become a Speaker
  • Subscribe
  • Terms
  • Privacy

© 2026 Industry Events Worldwide. All rights reserved.

VF101.4.
  • Events
  • News
  • Insights
  • Account
Industry Events
EnglishFrançaisEspañol中文العربية
EventsNewsInsightsOrganisers
Services
  • Event MarketingList, promote and grow your events to a global B2B audience.
  • Press ReleaseDistribute official announcements to industry professionals worldwide.
  • Speaker & SME PromotionShowcase expertise, get booked for keynotes, panels and masterclasses.
Subscribe
Speaker Sign InList Your Free Event
  1. Home
  2. News
  3. STAT+: OpenEvidence launches new family of AI models

STAT News

STAT+: OpenEvidence launches new family of AI models

In this edition of STAT Health Tech: What FDA's TEMPO pilot means for AI regulation, OpenEvidence launches new AI models, and more.

Continue with the complete report on the publisher’s website.

Read full article at STAT News
S

By STAT News

3 September 2026|1 min read
Share
Health Tech
STAT+: OpenEvidence launches new family of AI models
STAT+: OpenEvidence launches new family of AI models
Share
← Back to IE News

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

  • STAT+: Ultragenyx drug to treat Angelman syndrome, a rare disease, fails late-stage trial

    STAT News

    STAT+: Ultragenyx drug to treat Angelman syndrome, a rare disease, fails late-stage trial

    2 September 2026
  • STAT+: How Trump’s latest pharma deals may undermine efforts to rein in drug costs

    STAT News

    STAT+: How Trump’s latest pharma deals may undermine efforts to rein in drug costs

    2 September 2026
  • ‘Tactical athletes’ get new guidance for cardiovascular fitness

    STAT News

    ‘Tactical athletes’ get new guidance for cardiovascular fitness

    3 September 2026
  • STAT+: Fauci speaks, and writes

    STAT News

    STAT+: Fauci speaks, and writes

    3 September 2026
  • STAT+: ARPA-H funds biotechs working on custom RNA therapies

    STAT News

    STAT+: ARPA-H funds biotechs working on custom RNA therapies

    2 September 2026
  • STAT+: Abivax has still not been acquired. What’s going on?

    STAT News

    STAT+: Abivax has still not been acquired. What’s going on?

    3 September 2026

Related Insights

  • Advanced manufacturing and industrial AI

    Rare Earth Elements: The Invisible Engine of Modern Life

    11 Aug 202610 min read
  • Smart agriculture and food technology

    The Future of Food: Vertical & Indoor Farming Is Becoming a Serious Growth Industry

    Vertical farming cuts water use 90%, grows food anywhere, anytime—and with costs plummeting, it’s both a climate lifeline and a trillion-dollar investment bet.

    2 Aug 202610 min read
  • Precision medicine and longevity

    AI Series: Predictive HealthCare

    Predictive and Preventive medicine is quietly rewiring how care works. Here's what's changing, what's real, and how to get ahead of it.

    28 Jul 202614 min read
Browse all insights →

Related Events

  • Project Finance & Project Financial Modelling - Oct 2026

    19 Oct 2025
  • ADIHEX 2026 (Abu Dhabi International Hunting and Equestrian Exhibition)

    28 Aug 2026
    Abu Dhabi, United Arab Emirates
  • International Built Environment Week (IBEW) 2026

    2 Sept 2026
    Singapore
  • BeautyEurasia

    2 Sept 2026
    Turkey
Browse All Events→

More From The Newsroom

  • Why are drug overdose deaths declining?

    Why are drug overdose deaths declining?

    3 September 2026
  • Doctors groups release vaccination guidelines ahead of respiratory illness season

    Doctors groups release vaccination guidelines ahead of respiratory illness season

    2 September 2026
  • STAT+: Seattle scientists launch $95 million AI biology effort

    STAT+: Seattle scientists launch $95 million AI biology effort

    3 September 2026
  • STAT+: Ionis wins FDA approval for first drug for Alexander disease, a rare and deadly neurological disorder

    STAT+: Ionis wins FDA approval for first drug for Alexander disease, a rare and deadly neurological disorder

    3 September 2026
Industry Events

The world's most trusted B2B event discovery platform. Connecting industry professionals with the conferences, expos and summits that matter.

  • Industry Events
  • News
  • Event Organisers
  • About Us
  • Our Services
  • Premium Organiser
  • Event Pro
  • Become a Speaker
  • Subscribe
  • Terms
  • Privacy

© 2026 Industry Events Worldwide. All rights reserved.

VF101.4.